SAINT BELLA Inc (2508) Fair Value & Analysis
Healthcare · HK · Market cap HK$2.1B
Fair value as of: Aug 13, 2026
From 15 valuation models · updated 3 days ago
Fair value updated Aug 13, 2026, revised from HK$4.88 to HK$6.12 (+25.4%) since Aug 6, 2026. Share price −3.9% over the past month.
A solid business, screening 89% undervalued on our models.
What matters now
- The price is below even our cautious bear case (HK$4.59). The market is more pessimistic than our downside scenario.
- Solid quality (61/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (14 months)
White line = price, green steps = our fair value per fiscal year. As of Aug 13, 2026.
How to read this chart
14‑month range HK$3.08 – HK$8.80 · fair‑value band HK$4.59 – HK$7.65 · the HK$3.23 price screens below the HK$6.12 fair value. As of Aug 13, 2026.
Analysis
SAINT BELLA Inc (2508) currently trades at HK$3.23, while our model-based Fair Value estimate is HK$6.12, implying the stock looks roughly 89.5% undervalued today. The Quality Score stands at 61/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, SAINT BELLA Inc generated revenue of HK$1.0B at a net margin of 39.0%. Revenue grew 35.3% year over year. The stock trades on a trailing P/E of 10.7 (as of Jul 2, 2026). Fundamentals as of Aug 13, 2026
Our scenario range runs from HK$4.59 (bear case) to HK$7.65 (bull case); at HK$3.23, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 62% below its 52-week high, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -14% fair-value upside, at 89%, 2508 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 15 models by family
Widest divergence: Growth Earnings (HK$30.29) versus Asset-Based (HK$1.06). Highest evidence: ROIC Compounder (72).
Notify me when 2508 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 61 · Market factors (momentum, volatility) 12
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Saint Bella Group Limited engages in the operation of postpartum care centers, home care services, and food products business in China, Hong Kong, Singapore, the United States, and internationally. It offers postpartum care services under the Saint Bella and Baby Bella brands; and software development, as well as manufactures and sells apparel.
Full company description
Saint Bella Group Limited engages in the operation of postpartum care centers, home care services, and food products business in China, Hong Kong, Singapore, the United States, and internationally. It offers postpartum care services under the Saint Bella and Baby Bella brands; and software development, as well as manufactures and sells apparel. The company was formerly known as SAINT BELLA Inc. and changed its name to Saint Bella Group Limited in February 2026. Saint Bella Group Limited was founded in 2023 and is headquartered in Hangzhou, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
SAINT BELLA Inc reported revenue of HK$1.0B in FY2025 versus HK$259M in FY2021, a compound +41.8%/yr. Reported net income was HK$408M in FY2025.
Watch 2508: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 266 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $414.59 | $547.67 | +32% |
| Fresenius SE FRE | €46.82 | €32.15 | -31% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.67 SGD | 1.44 SGD | -46% |
| Tenet Healthcare Corporation THC | $266.79 | $330.25 | +24% |
| Rede D'Or São Luiz S.A RDOR3 | R$33.97 | R$47.31 | +39% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,565 | ₹2,955 | -65% |
| Aier Eye Hospital Group 300015 | ¥8.87 | ¥7.67 | -14% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,008 | ₹284.87 | -72% |
| Bangkok Dusit Medical Services Public Company BDMS | 19.70 THB | 18.57 THB | -6% |
Compare SAINT BELLA Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is SAINT BELLA Inc (2508) overvalued or undervalued?
What is the fair value of 2508?
What is the quality score of 2508?
What is the revenue of SAINT BELLA Inc (2508)?
What is the net profit margin of 2508?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track SAINT BELLA Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.